[
    {
        "id": 0,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n27. 根据国家药品监督管理局，公安部，国家卫⽣健康委员会的有关规定，⼜服固体制剂每剂量单位含羟考酮碱不超过5毫克，且不含其他⿇醉药品，精神药品或者药品类易制毒化学品的复⽅制剂列⼊（）。\nA. 含⿇醉药品复⽅制剂的管理\nB. 第⼆类精神药品管理\nC. 第⼀类精神药品管理\nD. 医疗⽤毒性药品管理\n\n**Step 1: Question Type Identification**\n- 最佳选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To analyze the question using the outlined process, let's proceed step by step:\n\n**Step 1: Question Type Identification**\n- This is a best choice multiple-choice question.\n\n**Step 2: Key Information Extraction**\n- Key information from the question includes:\n  - Oral solid dosage form\n  - Each unit contains oxycodone not exceeding 5 mg\n  - Does not contain other narcotic drugs, psychotropic substances, or precursor chemicals\n  - Request to categorize based on management regulations\n\n**Step 3: Systematic Analysis**\n- According to Chinese regulations, the management of compound preparations containing narcotics or psychotropic substances is based on their content and potential for abuse.\n- Oxycodone is a controlled substance, typically managed under narcotics or psychotropic regulations if present in significant amounts.\n- However, low-dose formulations with less than 5 mg per unit and not containing other scheduled substances have specific management rules.\n\n**Step 4: Cross-verification**\n- According to the latest guidelines from the National Medical Products Administration (NMPA), Ministry of Public Security, and National Health Commission:\n  - Compound preparations with narcotics like oxycodone not exceeding specific low-dose thresholds, and without additional narcotics or psychotropic drugs materials, follow less stringent management.\n  - This typically aligns with the management of \"compound preparations containing narcotics\" specific regulations, stepping them down from strict controls.\n  \n**Step 5: Final Confirmation**\n- The options provided are related to different drug management categories.\n- These low-dose preparations of narcotic compounds without other controlled substances are typically managed under the category for \"containing narcotic drugs compound preparations,\" which is the less strict regime.\n  \nTherefore, the correct choice for the management of these types of preparations is:\n\nCorrect answer: A. 含⿇醉药品复⽅制剂的管理",
        "question_type": "最佳选择题",
        "groundtruth": "B",
        "model_choice": "A"
    },
    {
        "id": 1,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n112. 患者，男，70岁，因抑郁症长期服⽤舍曲林。新诊断为帕⾦森病，宜选⽤的药物有（）。\nA. 司来吉兰\nB. 普拉克索\nC. ⾦刚烷胺\nD. 吡贝地尔\nE. 恩他卡朋\n\n**Step 1: Question Type Identification**\n- 多项选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To solve this question, we will follow the outlined rigorous process:\n\n**Step 1: Question Type Identification**\n- This is a multiple-choice question (多项选择题).\n\n**Step 2: Key Information Extraction**\n- The patient is a 70-year-old male with depression, currently on sertraline (an SSRI), and newly diagnosed with Parkinson's disease.\n- We need to identify which medication is appropriate for treating Parkinson's disease in this patient.\n\n**Step 3: Systematic Analysis**\n- Parkinson's disease treatment aims to manage symptoms such as tremor, rigidity, and bradykinesia and often involves medications that either replenish dopamine or mimic its action.\n- Key issue: The patient is on sertraline, a selective serotonin reuptake inhibitor (SSRI), which might interact with other drugs.\n- Let's analyze each option:\n  - A. 司来吉兰 (Selegiline): A monoamine oxidase B (MAO-B) inhibitor, can be used in early Parkinson's disease. It increases dopaminergic activity and may have potential interactions with SSRIs, increasing the risk of serotonin syndrome.\n  - B. 普拉克索 (Pramipexole): A dopamine agonist, effective in treating Parkinson's symptoms. Generally well-tolerated and often used as an initial treatment in older patients to delay the use of L-DOPA.\n  - C. ⾦刚烷胺 (Amantadine): Can be used to treat dyskinesia in Parkinson's patients and has some modest efficacy on symptoms. However, not typically a first-line choice for initial therapy, especially in elder patients due to potential cognitive side effects.\n  - D. 吡贝地尔 (Piribedil): Another dopamine agonist used for symptomatic relief in Parkinson's disease. It has a similar function to pramipexole.\n  - E. 恩他卡朋 (Entacapone): A COMT inhibitor, used to enhance the effect of L-DOPA. It is not used as monotherapy and only helpful when introduced with L-DOPA.\n\n**Step 4: Cross-verification**\n- Analyzing clinical guidelines and pharmacological profiles for Parkinson's disease and drug-drug interactions with SSRIs, dopamine agonists like Pramipexole (B) and sometimes Piribedil (D) are recommended for better safety profiles and effectiveness in elderly patients without needing to co-administer with L-DOPA initially.\n- Selegiline poses a risk when combined with SSRIs due to serotonin syndrome.\n\n**Step 5: Final Confirmation**\n- Based on the analysis, the drugs that best fit an elderly patient with the newly diagnosed Parkinson's who is on an SSRI (sertraline) are Pramipexole (B) and potentially Piribedil (D), considering Selegiline (A) can have interactions.\n\nCorrect answer: B, D",
        "question_type": "多项选择题",
        "groundtruth": "BCDE",
        "model_choice": "BD"
    },
    {
        "id": 4,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n19. 根据药品管理法律法规及相关⽂件的规定，药品零售企业可以开架⾃选销售的药品是（）。\nA. 复⽅⽢草⽚\nB. 复⽅⾦银花颗粒\nC. 复⽅地芬诺酯⽚\nD. 复⽅枇杷喷托维林颗粒\n\n**Step 1: Question Type Identification**\n- 最佳选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To determine which drug a retail pharmacy can sell as over-the-counter (open-shelf self-selection), we need to analyze based on the Drug Administration Law and relevant regulations concerning over-the-counter (OTC) medications in China. Here's how to approach this:\n\n### Step 1: Question Type Identification\n- This is a single best choice question.\n\n### Step 2: Key Information Extraction\n- Focus on which drugs are eligible for open-shelf self-selection in retail settings.\n\n### Step 3: Systematic Analysis\n- In China, only certain OTC drugs can be placed on open shelves for consumers to choose independently. Typically, these are non-prescription drugs deemed safe and are approved by regulatory authorities for OTC sale.\n\n### Step 4: Cross-verification\n- We refer to guidelines such as the \"Drug Administration Law\" of China and the definition of OTC drugs regarding retail pharmacy practices. Generally, drugs containing codeine or other habit-forming substances are not OTC.\n\n#### Analysis of the Options:\n- A. **复方甘草片** (Compound Glycyrrhiza Tablets): Often used as a remedy for coughing, this medication is generally considered safe and is sold as OTC, so it can be open-shelf.\n- B. **复方金银花颗粒** (Compound Honeysuckle Granules): Primarily used for clearing heat and detoxifying, this is recognized as an OTC medicine suitable for open-shelf sale.\n- C. **复方地芬诺酯片** (Compound Diphenoxylate Tablets): This is an anti-diarrheal medication containing diphenoxylate, which is similar to prescription medicines because of its potential for abuse.\n- D. **复方枇杷喷托维林颗粒** (Compound Loquat Pentoxyverine Granules): Typically used for cough and considered relatively safe; it is also OTC but must be verified against current OTC lists.\n\n### Step 5: Final Confirmation\n- Given the constraints on retail pharmacy practices, especially regarding consumer self-selection, options that have potential for misuse, or require specific guidance, such as option C, will not be open-shelf items.\n\n**Correct answer**: A, B, D",
        "question_type": "最佳选择题",
        "groundtruth": "B",
        "model_choice": "A"
    },
    {
        "id": 5,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n2. 影响药物制剂稳定性的⾮处⽅因素是（）。\nA. pH\nB. 温度\nC. 溶剂\nD. 离⼦强度\nE. 表⾯活性剂\n\n**Step 1: Question Type Identification**\n- 最佳选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "**Step 1: Question Type Identification**\nThe question is a multiple-choice question where the task is to identify factors that influence the stability of drug formulations.\n\n**Step 2: Key Information Extraction**\nKey information to consider includes:\n- Stability of drug formulations\n- Non-formulation-related factors\n\n**Step 3: Systematic Analysis**\nFactors influencing the stability of drug formulations, particularly non-formulation-related, typically include physical and chemical conditions that the formulation may be exposed to:\n\nA. pH: The acidity or alkalinity of the environment can affect the chemical stability of the drug.\nB. 温度 (Temperature): Variations in temperature can lead to physical or chemical instability.\nC. 溶剂 (Solvent): While solvents are part of the formulation, they can also independently affect stability by facilitating reactions.\nD. 离子强度 (Ionic Strength): Changes in the ionic environment can affect chemical stability and solubility.\nE. 表⾯活性剂 (Surfactants): These are generally added to the formulation to improve properties and can affect stability.\n\nAll these factors, while sometimes directly related to the formulation itself, are considered when assessing the external conditions that impact stability.\n\n**Step 4: Cross-verification**\nThis step involves verifying the influence of various factors based on pharmacological principles and stability science. All the listed factors (A, B, C, D, E) have an established impact on the stability of drug formulations as per theoretical and practical guidelines in pharmaceutical sciences.\n\n**Step 5: Final Confirmation**\nThe question asks for all non-formulation factors affecting stability. As each listed option has external influence capability, the correct answer includes all options.\n\nCorrect answer: A, B, C, D, E",
        "question_type": "最佳选择题",
        "groundtruth": "B",
        "model_choice": "A"
    },
    {
        "id": 11,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n22. 关于药品标签、说明书管理的说法，错误的是（）。\nA. 同⼀药品上市许可持有⼈⽣产的同⼀药品，分别按处⽅药与⾮处⽅药管理的，⼆者包装颜⾊必须明显区别\nB. 由于包装尺⼨或者技术设备等原因，标签中的有效期⽆法标注“有效期⾄某年某⽉”的，可以标注有效期实际期限\nC. 对贮藏有特殊要求的药品，应当在标签的醒⽬位置注明\nD. 药品内标签⾄少应当标注药品通⽤名称、产品批号和有效期\n\n**Step 1: Question Type Identification**\n- 最佳选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "Based on the analysis of the provided question regarding drug labeling and instructions, let's go through the steps:\n\n**Step 1: Question Type Identification**\n- This is a \"最佳选择题\" (best choice question), which typically requires identifying the incorrect statement among the given options.\n\n**Step 2: Key Information Extraction**\n- The focus is on the management of drug labels and instructions.\n- Keywords from the statements include:\n  - \"上市许可持有人\" (Market authorization holder)\n  - \"处方药\" (Prescription drug)\n  - \"非处方药\" (Over-the-counter drug)\n  - \"包装颜色\" (Packaging color)\n  - \"有效期\" (Expiry date)\n  - \"贮藏要求\" (Storage requirements)\n  - \"药品通用名称、产品批号\" (Generic name, batch number)\n\n**Step 3: Systematic Analysis**\n- Statement A: For the same drug produced by the same license holder, the packaging color must be distinctly different for prescription and non-prescription versions. This is a standard practice to prevent errors in dispensing and use.\n- Statement B: Generally, regulations require precise expiry date labeling (\"有效期至某年某月\"). However, based on technical reasons, labeling the exact validity period could be justified but might not align with the precise regulatory requirement for expiry date.\n- Statement C: Drugs with special storage requirements should indeed have this information prominently on the label to ensure proper handling.\n- Statement D: Internal labels must at least include the generic name, product batch number, and expiry date, which is a regulatory standard.\n\n**Step 4: Cross-verification**\n- Referencing regulations such as the \"Drug Administration Law\" or relevant guidelines:\n  - It is well-documented that distinct packaging helps differentiate between drug types (Statement A).\n  - Expiry dates typically require the format \"有效期至某年某月\" unless very specific exceptions apply, which are uncommon (some flexibility exists but might not be standard practice) (Statement B).\n  - Special storage conditions are expected to be clearly marked (Statement C).\n  - Essential information on internal labels is mandatory (Statement D).\n\n**Step 5: Final Confirmation**\n- Based on the typical regulatory standards, Statement B is the most likely to be incorrect or not fully aligned with standard practice because it suggests marking just the validity period without the explicit expiry format due to technical reasons, which is less likely allowed under strict regulations.\n\nCorrect answer: [B]",
        "question_type": "最佳选择题",
        "groundtruth": "D",
        "model_choice": "B"
    },
    {
        "id": 17,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n117. 药物代谢是机体对药物的处置过程，下列关于药物代谢的说法，正确的有（）。\nA. ⾮甾体抗炎药舒林酸结构中的甲基亚砜，经还原后的代谢物才具有活性\nB. 抗抑郁药丙⽶嗪结构中的⼆甲胺⽚段，经N-脱甲基后的代谢物失去活性\nC. 驱⾍药阿苯达唑结构中的丙硫醚，经S-氧化后的代谢物才具有活性\nD. 抗癫痫药苯妥英钠结构中的⼀个芳环，发⽣氧化代谢后产⽣羟基化的代谢物仍具有活性\nE. 解热镇痛药保泰松结构中的⼀个芳环，发⽣氧化代谢后产⽣羟基化的保泰松仍具有活性\n\n**Step 1: Question Type Identification**\n- 多项选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "In analyzing the question regarding drug metabolism, we begin by breaking down each statement:\n\nA. **非甾体抗炎药舒林酸** - The statement claims that the methyl sulfoxide group in Sulindac is reduced to an active metabolite. This is correct as Sulindac is a prodrug that is metabolized to its active form through reduction.\n\nB. **抗抑郁药丙米嗪** - The statement suggests that N-demethylation of Imipramine (a tricyclic antidepressant) leads to inactive metabolites. This is incorrect, as N-demethylation of Imipramine forms Desipramine, which is an active metabolite.\n\nC. **驱虫药阿苯达唑** - The statement indicates that Sulfoxidation of Albendazole leads to an active metabolite. Albendazole indeed undergoes sulfoxidation to Albendazole sulfoxide, an active form that exerts its antiparasitic effects.\n\nD. **抗癫痫药苯妥英钠** - The statement suggests that oxidation of a phenyl ring in Phenytoin results in a hydroxylated metabolite with retained activity. This is correct, as hydroxylation of Phenytoin (usually at the para position) forms active metabolites.\n\nE. **解热镇痛药保泰松** - The statement claims that hydroxylation of a phenyl ring in Phenylbutazone results in an active metabolite. This is incorrect, as while hydroxylation occurs, the metabolite's activity is not retained at therapeutically relevant levels.\n\nBased on this analysis, the correct options are A, C, and D.\n\nCorrect answer: A, C, D",
        "question_type": "多项选择题",
        "groundtruth": "ACE",
        "model_choice": "ACD"
    },
    {
        "id": 19,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n37. 根据医疗器械分类管理规定，下列属于⼆类医疗器械的是（）。\nA. 体温计、⽪肤缝合钉、⽆菌医⽤⼿套\nB. 超声三维系统软件、⾎压计、核磁共振成像设备\nC. 针灸针、听诊器、医⽤防护服\nD. 集液袋、⼿术⼑、睡眠监护系统软件\n\n**Step 1: Question Type Identification**\n- 最佳选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To solve the question regarding which items belong to the category of Class II medical devices under the regulations governing the classification of medical devices in China, we will follow the specified rigorous process.\n\n**Step 1: Question Type Identification**\n- This is a multiple-choice question where the best option must be selected.\n\n**Step 2: Key Information Extraction**\n- We need to identify which items listed fall under Class II medical devices. Key terms include \"Class II medical devices,\" and the examples given.\n\n**Step 3: Systematic Analysis**\n- In the Chinese medical device classification system:\n  - Class I devices are those with low risk, subject only to routine regulation.\n  - Class II devices are moderate-risk devices that require more stringent regulatory controls.\n  - Class III devices are high-risk devices that require the highest level of regulation.\n\n- Analyze each group of devices:\n  - **Option A (体温计, 皮肤缝合钉, 无菌医用手套):** These items typically come under Class I because they are generally low-risk (e.g., thermometers, sterile gloves) or border on Class II for slightly more extensive controls (e.g., skin staplers).\n  - **Option B (超声三维系统软件, 血压计, 核磁共振成像设备):** Items like blood pressure monitors are typically Class II, as they possess moderate risk requiring stronger oversight. Ultrasound software and MRI equipment can be Class II or Class III depending on specific definitions.\n  - **Option C (针灸针, 听诊器, 医用防护服):** Stethoscopes and acupuncture needles often fall into Class I due to low risk, though some may fluctuate into Class II. Medical protective clothing usually is Class I or more regulated during health crises.\n  - **Option D (集液袋, 手术刀, 睡眠监护系统软件):** Surgical knives and drainage bags are more inclined towards Class II given the need for control, while sleep monitoring software can range in classification based on complexity.\n\n**Step 4: Cross-verification**\n- Reviewing this in the context of regulations such as the Chinese \"Medical Device Classifications Rules\", it's confirmed that devices like blood pressure monitors are reliably Class II.\n\n**Step 5: Final Confirmation**\n- With the systematic analysis and cross-verification, the answer that best fits the question is Option B, due to the inclusion of items generally recognized as Class II under current classifications: 超声三维系统软件, 血压计, and 核磁共振成像设备.\n\nCorrect answer: B",
        "question_type": "最佳选择题",
        "groundtruth": "A",
        "model_choice": "B"
    },
    {
        "id": 20,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n14. ⽤烯丙基、环丙基甲基或环丁基甲基对吗啡及其类似物的叔胺部分进⾏修饰后，由阿⽚受体激动剂转为拮抗剂，属于阿⽚受体拮抗剂的是（）。\n\n\n**Step 1: Question Type Identification**\n- 最佳选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To address the question accurately and systematically, we will follow your specified process:\n\n**Step 1: Question Type Identification**\n- This is a multiple-choice question asking for the identification of a compound that acts as an opioid receptor antagonist following specific chemical modifications.\n\n**Step 2: Key Information Extraction**\n- Keywords and core requirements: \"烯丙基\", \"环丙基甲基\", \"环丁基甲基\", \"吗啡及其类似物\", \"阿片受体激动剂转为拮抗剂\", \"阿片受体拮抗剂\".\n\n**Step 3: Systematic Analysis**\n- This is a drug-related question. Morphine and its analogs with tertiary amine groups can be modified to change their activity. The specific modifications mentioned—introducing allyl, cyclopropylmethyl, or cyclobutylmethyl groups—are known to convert opioid receptor agonists into antagonists.\n- The attachment of these groups to the nitrogen of the tertiary amine in morphine derivatives typically results in compounds like naloxone or naltrexone, which are well-known opioid receptor antagonists.\n- This is based on pharmacological principles where structural modifications alter receptor binding and activity profiles.\n\n**Step 4: Cross-verification**\n- Historically, naloxone (with an allyl group) and naltrexone (with a cyclopropylmethyl group) are examples of opioid antagonists derived from such modifications.\n- Cross-reference with pharmacological texts and clinical guidelines confirms that these modifications are standard for converting opioid agonists to antagonists.\n\n**Step 5: Final Confirmation**\n- The conversion of opioid receptor agonists to antagonists via the specified modifications is a well-established pharmacological principle. Answer should completely align with the pharmacological transition described.\n\nTherefore, the correct answer would include options corresponding to compounds modified with these groups, specifically those known in pharmacology such as naloxone or naltrexone. \n\nCorrect answer: [option letters] (Note: Since there are no specific options provided, we can't assign letters. Commonly for such questions, look for choices that align with known antagonists like naloxone or naltrexone in a test setting.)",
        "question_type": "最佳选择题",
        "groundtruth": "A",
        "model_choice": "C"
    },
    {
        "id": 25,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n83. 结构中引⼊甲磺酰基，通过氢键作⽤增⼤了与酶的结合能⼒，使药效增强的药物是（）。\n\n\n**Step 1: Question Type Identification**\n- 配伍选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To address this question using the structured process outlined, let’s proceed step by step:\n\n**Step 1: Question Type Identification**\n- 配伍选择题 (Matching or multiple choice question)\n\n**Step 2: Key Information Extraction**\n- Keywords: 结构 (structure), 引入 (introduce), 甲磺酰基 (methanesulfonyl group), 氢键 (hydrogen bond), 增大结合能力 (increase binding ability), 药效增强 (enhance efficacy), 药物 (drug)\n\n**Step 3: Systematic Analysis**\n- The question asks for a drug that has increased its binding ability and efficacy through the introduction of a methanesulfonyl group, likely via hydrogen bonding with an enzyme.\n- We should analyze drugs that include a methanesulfonyl group in their structure. This group can form hydrogen bonds due to its sulfonyl component, thus potentially improving interaction with target enzymes and enhancing drug efficacy.\n\n**Step 4: Cross-verification**\n- We would cross-reference common drugs that include a methanesulfonyl group and confirm their mechanism involving increased binding through hydrogen bonding.\n- Potential references would include pharmacology textbooks, medicinal chemistry literature, and recent clinical studies.\n\n**Step 5: Final Confirmation**\n- The final step is to identify which known drugs fit this mechanism.\n\nA common example of a drug that uses a methanesulfonyl group to improve efficacy through an increase in binding ability is a type of sulfonylurea used in diabetes medications. However, without specific options listed, it is not possible to definitively state the correct answer. Typically, you'd find options like tolbutamide, glipizide, or other sulfonylureas in this context.\n\nCorrect answer: [This would typically be the letter corresponding to a relevant option if choices were provided, e.g., \"A\", \"B\", etc.]",
        "question_type": "配伍选择题",
        "groundtruth": "C",
        "model_choice": "B"
    },
    {
        "id": 35,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n47. 根据《中共中央国务院关于深化医疗保障制度改⾰的意见》，⼒争到2030年全⾯建成多层次医疗保障制度体系，多层次医疗保障制度体系中发挥托底作⽤的是（）。\nA. 补充医疗保险\nB. 医疗互助\nC. 医疗救助\nD. 基本医疗保险\n\n**Step 1: Question Type Identification**\n- 配伍选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "**Step 1: Question Type Identification**\n\n- 配伍选择题 (Matching choice question)\n\n**Step 2: Key Information Extraction**\n\n- Keywords: 《中共中央国务院关于深化医疗保障制度改⾰的意见》, 2030年全⾯建成, 多层次医疗保障制度体系, 托底作⽤\n- Core Requirement: Identify which component of the multi-level medical insurance system plays a foundational or basic support role.\n\n**Step 3: Systematic Analysis**\n\n- The question refers to a multi-tiered health insurance system as envisioned in the policy document guiding China's healthcare reform. The specific term \"托底作用\" (bottom-line support) suggests an element that provides fundamental or basic coverage.\n\n1. **补充医疗保险 (Supplementary Medical Insurance):** Additional coverage beyond basic needs, typically for services not covered by the base insurance.\n   \n2. **医疗互助 (Medical Mutual Assistance):** Community-based or group support that provides insurance-type benefits; not typically core or foundational.\n\n3. **医疗救助 (Medical Assistance):** Targeted at aiding those who cannot afford medical services; provides foundational support for the underprivileged.\n\n4. **基本医疗保险 (Basic Medical Insurance):** Forms the core of China's healthcare system providing primary, essential coverage for the population.\n\n**Step 4: Cross-verification**\n\n- These roles can be verified against the objectives of the healthcare reform policy which emphasizes basic healthcare accessibility and cost control. As \"基本医疗保险\" provides the basic, essential coverage, it is designed to ensure that people's basic healthcare needs are met, thus performing the \"托底作用\".\n\n**Step 5: Final Confirmation**\n\n- Confirm that the answer choice is comprehensive and without error. In the context of the reform policy, the correct choice for an element that plays the foundational role in the healthcare system is:\n\nCorrect answer: D. 基本医疗保险",
        "question_type": "配伍选择题",
        "groundtruth": "C",
        "model_choice": "D"
    },
    {
        "id": 38,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n题干：甲是药品上市许可持有⼈，依法持有甲钴胺⽚等药品品种； ⼄是药品⽣产企业，⽣产范围：⽚剂、胶囊剂； 丙是药品⽣产企业，⽣产范围：胶囊剂、颗粒剂； 丁是全国性药品批发企业，经营范围：⿇醉药品、中成药、中药饮⽚、化学药、⽣物制品，具备药品现代物流条件； 戊是县级区域性药品批发企业，经营范围：中成药、化学药； ⼰是药品零售连锁企业所属门店，经营类别：处⽅药、甲类⾮处⽅药、⼄类⾮处⽅药，经营范围：第⼆类精神药品、中成药、中药饮⽚、化学药。\n96. 药品监督管理部门检查发现⼰从个⼈处购进药品并销售，情节较轻，应当依法依规做出的处罚是（）。\nA. 责令改正，没收违法购进的药品和违法所得，并处违法购进药品货值⾦额⼆倍以上⼗倍以下的罚款，货值⾦额不⾜五万元的，按五万元计算\nB. 给予警告，责令限期改正：逾期不改正或者情节严重的，处以⼀千元以上三千元以下的罚款\nC. 没收违法销售的药品和违法所得，并处违法销售药品货值⾦额⼗倍以上⼆⼗倍以下的罚款，货值⾦额不⾜⼀万元的，按⼀万元计算\nD. 责令限期改正，予以警告：逾期不改正的，处⼗万元以上五⼗万元以下的罚款\n\n**Step 1: Question Type Identification**\n- 综合分析选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "**Step 1: Question Type Identification**\n\nThe question is a comprehensive analysis multiple-choice question that requires identification of the appropriate regulatory actions based on the situation described.\n\n**Step 2: Key Information Extraction**\n\n- Subject (己): A retail pharmacy chain store.\n- Action:己 has purchased and sold drugs from individuals.\n- Consequence: The situation is described as \"情节较轻\" (relatively minor).\n\n**Step 3: Systematic Analysis**\n\nThe question involves regulatory knowledge, specifically regarding the penalties for unauthorized purchase and sale of drugs by a pharmacy. Given that the action was purchasing from individuals (an unauthorized source) and the situation is minor, the relevant regulation would be about consequences for minor regulatory violations.\n\n- **Option A**: This option suggests a severe penalty which includes confiscation and a high-range monetary fine, likely intended for more serious infractions.\n- **Option B**: This option suggests a warning with a provision for a penalty if the situation is not corrected in time or if it is deemed serious.\n- **Option C**: This option refers to heavier penalties focused on illegal sales, including higher fines more suited for severe offenses.\n- **Option D**: This option indicates a possible mix of correction, warning, and a significant fine, seemingly more appropriate for serious infractions after a warning is ignored.\n\nConsidering the description of the situation as \"情节较轻\" (relatively minor), a lighter penalty with emphasis on correction should be more appropriate.\n\n**Step 4: Cross-verification**\n\nReferencing the \"Drug Administration Law\" and \"Good Supply Practice for Pharmaceutical Products\", regulatory responses for minor violations often involve warnings and corrective mandates, with heavier penalties reserved for severe or uncured violations.\n\n**Step 5: Final Confirmation**\n\nThe correct answer aligns with the principles of issuing a corrective mandate supplemented with a warning when the violation is minor:\n\nCorrect answer: B",
        "question_type": "综合分析选择题",
        "groundtruth": "A",
        "model_choice": "B"
    },
    {
        "id": 46,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n42. 根据《药品经营质量管理规范》，测量范围在－25℃～0℃之间的温湿度监测系统，测量设备的温度最⼤允许误差为（）。\nA. ±2.0℃\nB. ±0.5℃\nC. ±0.1℃\nD. ±1.0℃\n\n**Step 1: Question Type Identification**\n- 配伍选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To determine the correct answer to this question regarding the maximum allowable temperature error for a temperature monitoring system between -25℃ and 0℃ according to the \"Good Supply Practice for Pharmaceutical Products\" (药品经营质量管理规范), let's proceed through the outlined steps:\n\n**Step 1: Question Type Identification**\n\n- This is a multiple-choice question (配伍选择题).\n\n**Step 2: Key Information Extraction**\n\n- Keywords: 温湿度监测系统 (temperature and humidity monitoring system), －25℃～0℃ (measurement range), 温度最⼤允许误差 (maximum allowable temperature error)\n- Core requirement: Identify the maximum allowable error for temperature measurements within the specified range.\n\n**Step 3: Systematic Analysis**\n\n- Based on the \"Good Supply Practice for Pharmaceutical Products\", a monitoring system used for temperature-controlled storage typically has specific accuracy requirements.\n- Generally for such systems, the allowable temperature error is typically ±0.5℃ unless otherwise stated for specific cases involving extreme precision.\n\n**Step 4: Cross-verification**\n\n- Cross-check against authoritative sources or official guidelines such as the \"Good Supply Practice for Pharmaceutical Products\" or \"Good Distribution Practice\" (GDP) for verification.\n- Documentation usually specifies that, for monitoring within the range of storage conditions - especially for cold storage - an error margin close to ±0.5℃ is a standard requirement.\n\n**Step 5: Final Confirmation**\n\n- Based on regulatory guidelines and the systematic analysis above, and where typical accuracy requirements for such measurements are addressed, the temperature range monitoring systems usually adhere to a standard error allowance of ±0.5℃.\n\nHence, the correct answer is: **B. ±0.5℃**",
        "question_type": "配伍选择题",
        "groundtruth": "D",
        "model_choice": "B"
    },
    {
        "id": 47,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n120. 审⽅时要关注中西药联⽤的情况，下列药品中含有西药成分的有（）。\nA. ⿐炎康⽚\nB. 珍菊降压⽚\nC. 防风通圣丸\nD. 蛇胆川贝液\nE. 消渴丸\n\n**Step 1: Question Type Identification**\n- 多项选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To analyze the given question rigorously according to the outlined steps:\n\n**Step 1: Question Type Identification**\n- The question is a multiple-choice question (多项选择题), asking for identification of items containing Western medicine components.\n\n**Step 2: Key Information Extraction**\n- Keywords: \"中西药联用\" (combination of Chinese and Western medicine), \"含有西药成分的\" (contain Western medicine components)\n- Core requirement: Identify which listed Chinese medicines contain Western medicine ingredients.\n\n**Step 3: Systematic Analysis**\n- This question pertains to drug-related knowledge, specifically identifying active components in traditional Chinese medicine (TCM) products that also contain Western medicine ingredients.\n- Let's analyze each option:\n  - **A. 鼻炎康片**: Known to contain antihistamine (chlorpheniramine) which is a Western medicine component.\n  - **B. 珍菊降压片**: Primarily traditional Chinese ingredients; generally no Western medicine component.\n  - **C. 防风通圣丸**: Traditional herbal formula, no Western medicine component.\n  - **D. 蛇胆川贝液**: Traditional Chinese medicine product used for respiratory conditions; typically no Western medicine component.\n  - **E. 消渴丸**: Usually includes traditional Chinese ingredients aimed at managing blood sugar; no Western components.\n\n**Step 4: Cross-verification**\n- Based on pharmacological knowledge and formulation information:\n  - 鼻炎康片 (A) is the only one from the list that typically includes Western pharmacological components.\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully corresponds to the core requirement of identifying which options include Western medicine components.\n\nCorrect answer: [A]",
        "question_type": "多项选择题",
        "groundtruth": "ABE",
        "model_choice": "A"
    },
    {
        "id": 48,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n85. 根据《国家药品监督管理局职能配置、内设机构和⼈员编制规定》及其有关规定，负责执业药师管理信息系统的建设、管理和维护的是（）。\nA. 国家药品监督管理局⾼级研修学院\nB. 国家药品监督管理局执业药师资格认证中⼼\nC. 国家药典委员会\nD. 国家药品监督管理局信息中⼼\n\n**Step 1: Question Type Identification**\n- 配伍选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To address the question using the outlined process, I'll follow each step:\n\n**Step 1: Question Type Identification**\n- The question is a multiple-choice question (配伍选择题).\n\n**Step 2: Key Information Extraction**\n- The key information revolves around the responsibility for the construction, management, and maintenance of the pharmacist management information system as per regulations by the National Medical Products Administration.\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: The relevant body responsible for managing the pharmacist system would typically be associated with IT or information-related management within the regulatory framework. While high-level training, qualifications, and standards bodies are crucial, the direct responsibility for system maintenance is more likely under the purview of an IT or information management segment within the administration.\n\n**Step 4: Cross-verification**\n- As per official guidelines and the structural and functional regulations of the National Medical Products Administration, usually, the information or IT center would handle such systems.\n\n**Step 5: Final Confirmation**\n- Given the nature of the task and the entities listed, the correct entity responsible for managing and maintaining the pharmacist management information system should logically be the information center.\n\nCorrect answer: D. 国家药品监督管理局信息中心",
        "question_type": "配伍选择题",
        "groundtruth": "B",
        "model_choice": "D"
    },
    {
        "id": 53,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n57. 根据《药品经营质量管理规范》及其有关附录⽂件，属于保温箱特有的验证项⽬是（）。\nA. 测点终端安装数量及位置确认\nB. 测点终端参数与数据联动传输确认\nC. 运输最长时限验证\nD. 极端温度保温性能验证\n\n**Step 1: Question Type Identification**\n- 配伍选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "**Step 1: Question Type Identification**\n\n- The question is a multiple-choice question, as indicated by the selection of one option among several provided.\n\n**Step 2: Key Information Extraction**\n\n- Keywords and core requirements are related to the validation items specific to insulated boxes according to the \"Good Supply Practice for Pharmaceutical Products\" and its relevant addendum documents. The task is to identify which of the options is a unique validation item for insulated boxes.\n\n**Step 3: Systematic Analysis**\n\n- According to the \"Good Supply Practice for Pharmaceutical Products\", insulated boxes are designed to maintain a product's temperature within a specified range during transport.\n  - A. \"测点终端安装数量及位置确认\" (Confirmation of the quantity and location of measurement terminals) is not unique to insulated boxes; it's a general requirement for any device requiring temperature monitoring.\n  - B. \"测点终端参数与数据联动传输确认\" (Confirmation of parameter and data-link transmission of measurement terminals) is also a broad requirement for any data monitoring system.\n  - C. \"运输最长时限验证\" (Validation of the maximum transportation time limit) applies to many storage and transportation conditions, not solely to insulated boxes.\n  - D. \"极端温度保温性能验证\" (Validation of thermal insulation performance in extreme temperatures) is specific to insulated boxes as this ensures that substances are maintained at the required temperature even under extreme external environmental conditions.\n\n**Step 4: Cross-verification**\n\n- Referencing the latest \"Good Supply Practice for Pharmaceutical Products\", the requirement for insulated boxes to be tested for their ability to maintain specific temperature ranges, especially in extreme conditions, aligns with D. It is crucial for maintaining the quality and efficacy of temperature-sensitive pharmaceuticals.\n\n**Step 5: Final Confirmation**\n\n- Upon reviewing the requirements for the validation of insulated boxes, option D: \"极端温度保温性能验证\" is the uniquely relevant item specific to insulated boxes.\n\nCorrect answer: D",
        "question_type": "配伍选择题",
        "groundtruth": "C",
        "model_choice": "D"
    },
    {
        "id": 65,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n81. 在体外⽆活性，需要在体内⽔解开环发挥活性的药物是（）。\n\n\n**Step 1: Question Type Identification**\n- 配伍选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To answer the question regarding a drug that is inactive in vitro and requires hydrolysis and ring-opening in vivo to be active, we can follow the outlined process:\n\n**Step 1: Question Type Identification**\n- This is a multiple-choice question regarding pharmacology principles.\n\n**Step 2: Key Information Extraction**\n- Keywords and constraints: \"inactive in vitro\", \"hydrolysis\", \"ring-opening\", \"active in vivo\".\n\n**Step 3: Systematic Analysis**\nThis question involves understanding prodrugs -- inactive compounds that must undergo interconversion to release the active drug, usually via metabolic processes such as hydrolysis.\n\nExamples of such drugs typically include esters which undergo hydrolysis to become active. A classic example is:\n- **Proton Pump Inhibitors (PPIs)** like omeprazole, which are inactive at neutral pH but are converted to active forms under acidic conditions inside parietal cells.\n- **ACE Inhibitors** like enalapril which is a prodrug and is converted into the active form enalaprilat by hydrolysis.\n\n**Step 4: Cross-verification**\n- Verification with principles of pharmacology: Recognition of drug metabolism and prodrug concepts; Reference can be made to standard pharmacology textbooks or clinical resources.\n- Check guidelines: Refer to drug pharmacokinetics chapters or clinical pharmacology resources for specifics on prodrugs that require hydrolysis.\n\n**Step 5: Final Confirmation**\n- Based on the analysis and general pharmacological knowledge, such a question typically points towards common medications with prodrug characteristics. \n\nTherefore, the correct answer would typically involve a drug known to be a prodrug that activates via hydrolysis, such as an ACE inhibitor like enalapril. \n\nCorrect answer: [Enalapril or similar known pharmacological prodrug example].",
        "question_type": "配伍选择题",
        "groundtruth": "D",
        "model_choice": "E"
    },
    {
        "id": 70,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n52. 属于⿇醉药品的是（）。\nA. 氨酚待因⽚\nB. 氨酚氢可酮⽚\nC. 氢可酮\nD. 氯胺酮\n\n**Step 1: Question Type Identification**\n- 配伍选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To determine which of the given options is classified as a narcotic drug, we will follow the structured analysis process:\n\n**Step 1: Question Type Identification**\nThe question is a selection type (选择题), asking which of the listed options belongs to the category of narcotic drugs (麻醉药品).\n\n**Step 2: Key Information Extraction**\nKey elements to consider are the list of drugs provided in the options and the classification as narcotic drugs (麻醉药品).\n\n**Step 3: Systematic Analysis**\nWe need to identify which of these substances are considered narcotics in the context of pharmaceutical regulation and pharmacology:\n\n- **氨酚待因片 (Acetaminophen with Codeine):** A combination analgesic, the component codeine is an opioid and commonly recognized as a narcotic due to its use as a pain reliever and potential for abuse.\n\n- **氨酚氢可酮片 (Acetaminophen with Hydrocodone):** Another combination analgesic, hydrocodone is a potent opioid, classified as a narcotic for its efficacy in pain management and potential for abuse.\n\n- **氢可酮 (Hydrocodone):** An opioid analgesic, directly recognized as a narcotic due to its strong potential for addiction and regulation under various narcotic control laws.\n\n- **氯胺酮 (Ketamine):** Although used as an anesthetic, it is typically classified as a dissociative anesthetic, not a classical opioid narcotic. However, ketamine is often subject to separate control due to its potential for abuse and psychedelic effects.\n\n**Step 4: Cross-verification**\nReferencing international drug control agreements, such as those by the United Nations Office on Drugs and Crime (UNODC) and national regulations like the \"Drug Administration Law,\" confirms that opioids such as codeine and hydrocodone are classified as narcotics.\n\n**Step 5: Final Confirmation**\nThe correct classification relies on narcotics that are typically opioids. Based on this:\n\n- A: Acetaminophen with Codeine (氨酚待因片) contains codeine, a narcotic.\n- B: Acetaminophen with Hydrocodone (氨酚氢可酮片) contains hydrocodone, a narcotic.\n- C: Hydrocodone (氢可酮) itself is a narcotic.\n- D: Ketamine (氯胺酮) is not classified as a traditional narcotic but is regulated due to its other effects.\n\nCorrect answer: A, B, C",
        "question_type": "配伍选择题",
        "groundtruth": "C",
        "model_choice": "A"
    },
    {
        "id": 76,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n84. 根据《国家药品监督管理局职能配置、内设机构和⼈员编制规定》及其有关规定，负责组织开展执业药师考前培训、继续教育的是（）。\nA. 国家药品监督管理局⾼级研修学院\nB. 国家药品监督管理局执业药师资格认证中⼼\nC. 国家药典委员会\nD. 国家药品监督管理局信息中⼼\n\n**Step 1: Question Type Identification**\n- 配伍选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "**Step 1: Question Type Identification**\n\n- 配伍选择题 (Multiple choice question)\n\n**Step 2: Key Information Extraction**\n\n- Keywords: 《国家药品监督管理局职能配置、内设机构和人员编制规定》, 执业药师考前培训, 继续教育\n- Core requirement: Identify which organization is responsible for organizing pre-exam training and continuing education for licensed pharmacists.\n\n**Step 3: Systematic Analysis**\n\nIn accordance with the powers and responsibilities outlined in Chinese regulatory structures:\n\n- 国家药品监督管理局高级研修学院: Typically involved in high-level training and research, may not specifically focus on pharmacists.\n- 国家药品监督管理局执业药师资格认证中心: Directly linked to the certification and possibly the training for licensed pharmacists.\n- 国家药典委员会: Focuses on the development and revision of the Chinese Pharmacopoeia, not directly involved in pharmacist training.\n- 国家药品监督管理局信息中心: Primarily deals with information management and IT services, not training.\n\nBased on this structure, the 国家药品监督管理局执业药师资格认证中心 is most aligned with organizing pre-exam training and continuing education for licensed pharmacists.\n\n**Step 4: Cross-verification**\n\nVerify by referring to the most recent organizational documents and guidelines related to the National Medical Products Administration (NMPA):\n\n- The NMPA and its affiliated bodies define specific roles, and the body directly related to pharmacist qualifications is typically the one responsible for related educational programs.\n\n**Step 5: Final Confirmation**\n\nThe correct answer that fully meets the question requirements is:\n\nCorrect answer: B. 国家药品监督管理局执业药师资格认证中心",
        "question_type": "配伍选择题",
        "groundtruth": "A",
        "model_choice": "B"
    },
    {
        "id": 81,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n40. 兼有抑菌作⽤的⿐⽤减充⾎剂是（）。\nA. 呋⿇滴⿐液\nB. 赛洛唑啉滴⿐液\nC. 羟甲唑啉⿐喷剂\nD. ⿇黄碱滴⿐液\nE. 左氧氟沙星滴⿐液\n\n**Step 1: Question Type Identification**\n- 最佳选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To address the question, let's proceed through the rigorous process outlined:\n\n**Step 1: Question Type Identification**\n- This is a best-choice question, asking for the nasal decongestant with antibacterial properties.\n\n**Step 2: Key Information Extraction**\n- Keywords: \"抑菌作⽤\" (antibacterial effect), \"⿐⽤减充⾎剂\" (nasal decongestant).\n\n**Step 3: Systematic Analysis**\n- **呋麻滴鼻液 (A)**: Contains naphazoline or similar compounds typically acting as vasoconstrictors; not known for antibacterial effects.\n- **赛洛唑啉滴鼻液 (B)**: Contains xylometazoline hydrochloride, a vasoconstrictor, not typically noted for antibacterial effects.\n- **羟甲唑啉鼻喷剂 (C)**: Contains oxymetazoline hydrochloride, another vasoconstrictor without antibacterial properties.\n- **麻黄碱滴鼻液 (D)**: Contains ephedrine, a vasoconstrictor with no antibacterial activity.\n- **左氧氟沙星滴鼻液 (E)**: Contains levofloxacin, a fluoroquinolone antibiotic with antibacterial properties.\n\n**Step 4: Cross-verification**\n- Verify based on pharmacological principles: Out of the options given, levofloxacin (option E) is distinctly recognized as having antibacterial properties because it is a well-known antibiotic. None of the other listed nasal decongestants possess inherent antibacterial action as their main active principle targets vasoconstriction to relieve nasal congestion.\n\n**Step 5: Final Confirmation**\n- The requirements ask for a nasal decongestant with antibacterial properties. Levofloxacin (option E) meets this criterion as it is both an antibacterial agent and can be formulated for nasal use to combat infection-related congestion.\n\nCorrect answer: E",
        "question_type": "最佳选择题",
        "groundtruth": "A",
        "model_choice": "E"
    },
    {
        "id": 84,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n21. 关于疫苗流通管理的说法，错误的是（）。\nA. 疫苗上市许可持有⼈在销售疫苗时，应当提供加盖其印章的批签发证明复印件或者电⼦⽂件\nB. 疫苗上市许可持有⼈应当按照采购合同约定，向疾病防控制机构和接种单位直接供应疫苗\nC. 疫苗上市许可持有⼈应当按照规定，建⽴真实、准确完整的销售记录，并保存⾄疫苗有效期满后不少于五年备查\nD. 疾病预防控制机构、接种单位应当建⽴疫苗定期检查制度\n\n**Step 1: Question Type Identification**\n- 最佳选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "**Step 1: Question Type Identification**\n- The given question is a multiple choice question asking to identify the incorrect statement regarding the management of vaccine circulation.\n\n**Step 2: Key Information Extraction**\n- Key terms to focus on: \"疫苗流通管理\", \"上市许可持有人\", \"批签发证明复印件\", \"电⼦⽂件\", \"采购合同约定\", \"疾病防控制机构\", \"接种单位\", \"真实、准确完整的销售记录\", \"保存⾄疫苗有效期满后不少于五年备查\", \"定期检查制度\".\n\n**Step 3: Systematic Analysis**\n- Regulatory context: The analysis should be done considering Chinese regulations concerning vaccine management and circulation. Typically, these relate to proper documentation, direct supply chains, record-keeping, and quality control protocols.\n\nA. 疫苗上市许可持有⼈在销售疫苗时，应当提供加盖其印章的批签发证明复印件或者电⼦⽂件\n\n- This statement describes standard procedure for vaccine distribution where proof of batch release is provided by the vaccine holder. It is not likely to be incorrect.\n\nB. 疫苗上市许可持有⼈应当按照采购合同约定，向疾病防控制机构和接种单位直接供应疫苗\n\n- Direct supply as per contract to disease control and inoculation units is part of regulated vaccine distribution. This statement is accurate.\n\nC. 疫苗上市许可持有⼈应当按照规定，建⽴真实、准确完整的销售记录，并保存⾄疫苗有效期满后不少于五年备查\n\n- The duration for recordkeeping aligns with regulations concerning maintaining sales records post-vaccine expiry. This is correct.\n\nD. 疾病预防控制机构、接种单位应当建⽴疫苗定期检查制度\n\n- While regular inspection systems are plausible, this statement is less specific without regulatory foundation backing such a routine for disease control agencies and vaccination units.\n\n**Step 4: Cross-verification**\n- Verification involves checking current regulatory guidelines such as the \"Drug Administration Law\" and associated vaccine distribution protocols. The latest practices tend to enforce documentation and direct supply routes as required, while less emphasis may be on routine establishment of inspection systems outside of regulatory mandates.\n\n**Step 5: Final Confirmation**\n- After analysis, the statement least aligned with explicit regulatory protocols is potentially (D) concerning inspection establishment assumption by disease prevention and inoculation units without direct regulatory mandate.\n\nCorrect answer: D",
        "question_type": "最佳选择题",
        "groundtruth": "B",
        "model_choice": "D"
    },
    {
        "id": 85,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n题干：秦某是⼀所中医药⼤学中医学专业硕⼠毕业⽣，已获得硕⼠学位，在校期间学过中药材知识和栽培技术，具有中药材辨识能⼒。临近毕业时，准备参加执业药师职业资格考试，但因专业⼯作年限不符合报名条件，未能参加考试。 秦某的⽼家在边远⼭区，交通不便，为解决家乡群众看病难题，毕业后主动返乡当村医。平时除给乡邻治病之外，还在⾃家地⾥种植地产中药材。\n95. 根据《中医药法》，关于秦某种植地产中药材的说法，正确的是（）。\nA. 销售给当地的中药饮⽚⽣产企业\nB. 将⾃产中药材加⼯成中药制剂⽅便村民使⽤\nC. 在其开设的诊所中煎汤药给村民治病\nD. 种植仅供⾃⽤的医疗⽤毒性中药材\n\n**Step 1: Question Type Identification**\n- 综合分析选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To analyze this question, let's follow the structured process:\n\n**Step 1: Question Type Identification**\n- This is a comprehensive analysis multiple-choice question.\n\n**Step 2: Key Information Extraction**\n- Qin is a graduate in the field of Traditional Chinese Medicine and has returned to a remote home village to work as a village doctor, growing local Chinese medicinal materials.\n- Important key terms: \"中药材\", \"地产中药材\", \"法\", \"种植\", \"⾃⽤\", \"毒性中药材\".\n\n**Step 3: Systematic Analysis**\n- We must interpret Qin's activities in the context of Chinese laws regarding Traditional Chinese Medicine, specifically the \"中医药法\" (Law on Traditional Chinese Medicine) concerning the planting and usage of Chinese medicinal materials:\n\n  A. 销售给当地的中药饮片生产企业:\n     - Selling to local Chinese herbal decoction manufacturers is generally permissible, subject to compliance with relevant quality and safety requirements laid out in regulations.\n     \n  B. 将自产中药材加工成中药制剂方便村民使用:\n     - Processing self-grown Chinese medicinal herbs into preparations usually requires proper licenses and compliance with the regulations governing the manufacturing of Chinese medicinal products, which may not be permissible for an individual without specific approvals.\n\n  C. 在其开设的诊所中煎汤药给村民治病:\n     - If Qin is using the herbs in a medical practice with proper authorization, preparing herbal decoctions directly for treatment could be allowed under the supervision of a qualified practitioner.\n\n  D. 种植仅供自用的医用毒性中药材:\n     - Growing toxic medicinal herbs even for personal use often requires special permits due to their potentially dangerous nature and public health concerns. \n\n**Step 4: Cross-verification**\n- Reviewing the \"Law on Traditional Chinese Medicine\" and other relevant regulations would highlight that selling to accredited companies likely complies with practices for quality management in the supply chain.\n- Usage within an individual's practice for patient-specific treatments (option C) relies on the provisions granted to licensed practitioners.\n\n**Step 5: Final Confirmation**\n- The activities in options A and C align with regulated undertakings permissible under certain conditions laid out by the \"Law on Traditional Chinese Medicine\".\n\nCorrect answer: A, C",
        "question_type": "综合分析选择题",
        "groundtruth": "C",
        "model_choice": "A"
    },
    {
        "id": 92,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n56. 根据《药品经营质量管理规范》及其有关附录⽂件，属于温湿度⾃动监测系统特有的验证项⽬是（）。\nA. 测点终端安装数量及位置确认\nB. 测点终端参数与数据联动传输确认\nC. 运输最长时限验证\nD. 极端温度保温性能验证\n\n**Step 1: Question Type Identification**\n- 配伍选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To solve the question provided, I will follow the structured approach outlined:\n\n**Step 1: Question Type Identification**\n- The question is a multiple-choice (配伍选择题) question.\n\n**Step 2: Key Information Extraction**\n- Keywords: 《药品经营质量管理规范》 (Good Supply Practice for Pharmaceutical Products, GSP), 温湿度自动监测系统 (temperature and humidity automatic monitoring system), 验证项目 (validation items)\n- Core Requirement: Identify the unique validation items specifically for temperature and humidity automatic monitoring systems as per GSP.\n\n**Step 3: Systematic Analysis**\n- According to the GSP and pertaining appendices, systems that require validation for temperature and humidity monitoring are fundamental for maintaining storage conditions for pharmaceuticals. Unique validation items would relate to the specific capabilities and performance of the temperature and humidity monitoring system itself.\n\n1. **A. 测点终端安装数量及位置确认**: Involves confirmation of the number and location of installation points, which is a fundamental requirement for any monitoring system.\n   \n2. **B. 测点终端参数与数据联动传输确认**: Involves confirming that the system's parameters and data transmission are being relayed correctly. This is unique to ensuring the system operates correctly, which is crucial for automatic systems that report temperature and humidity.\n   \n3. **C. 运输最长时限验证**: Verification of the longest transportation time, which is not specific to the monitoring system itself, but rather relates to logistics.\n\n4. **D. 极端温度保温性能验证**: Validation of insulation performance under extreme temperatures is related to packaging or transportation conditions rather than direct system monitoring.\n\n**Step 4: Cross-verification**\n- Reference to the latest GSP or related guidelines should confirm that ensuring accurate parameter measurement and data transmission is intrinsic to the proper functioning of a temperature and humidity monitoring system.\n\n**Step 5: Final Confirmation**\n- A unique validation characteristic of an automatic system would indeed ensure correctness in data transmission to ensure real-time monitoring and alerts, aligning with option B.\n\nCorrect answer: [B]",
        "question_type": "配伍选择题",
        "groundtruth": "A",
        "model_choice": "B"
    },
    {
        "id": 97,
        "query": "You are a senior expert in the Chinese pharmaceutical field. Please analyze the question according to the following rigorous process:\n14. 根据下列部门的主要职责、内设机构和⼈员编制规定，负责提出国家基本药物价格政策建议的部门是（）。\nA. 国家医疗保障局\nB. 国家卫⽣健康委员会\nC. 国家发展和改⾰委员会\nD. 国家市场监督管理总局\n\n**Step 1: Question Type Identification**\n- 最佳选择题\n\n**Step 2: Key Information Extraction**\n- Mark keywords, constraints, and core requirements in the question\n\n**Step 3: Systematic Analysis**\n- For regulatory questions: Analyze based on relevant laws, regulations, and guidelines\n- For drug-related questions: Analyze based on pharmacological principles, clinical guidelines, and evidence-based medicine\n- For calculation questions: Analyze based on relevant formulas, calculation steps, and units\n\n**Step 4: Cross-verification**\n- For regulatory questions: Refer to the latest versions of \"Drug Administration Law\", \"Good Supply Practice for Pharmaceutical Products\", etc.\n- For drug-related questions: Base on pharmacological principles and clinical guidelines\n- For calculation questions: Perform complete calculation verification\n\n**Step 5: Final Confirmation**\n- Ensure the answer fully meets the question requirements\n- For multiple choice questions: Must select all correct options, without omission or over-selection\n\nPlease output: Correct answer: [option letters]\n",
        "model_answer": "To determine the correct answer for the department responsible for proposing national essential drug price policy recommendations, we will follow the outlined rigorous process:\n\n**Step 1: Question Type Identification**\n- The question is a \"最佳选择题\" (best choice question).\n\n**Step 2: Key Information Extraction**\n- Keywords: 国家基本药物价格政策建议 (national essential drug price policy recommendations), 部门 (department).\n- Core requirement: Identify which department is responsible for proposing these pricing policy recommendations.\n\n**Step 3: Systematic Analysis**\n- To analyze the responsibility for proposing essential drug price policies, we need to consider the role and responsibilities of each listed department:\n\n  A. 国家医疗保障局 (National Healthcare Security Administration): Primarily responsible for formulating policies on medical security, including medical insurance, and managing the pricing of drugs under the medical insurance system.\n\n  B. 国家卫生健康委员会 (National Health Commission): Responsible for overall health planning and policy, public health, and medical services, but not specifically drug pricing.\n\n  C. 国家发展和改革委员会 (National Development and Reform Commission): Historically involved in macroeconomic policy and pricing reforms, including some healthcare pricing reforms, but its direct role in drug pricing policy has reduced over time.\n\n  D. 国家市场监督管理总局 (State Administration for Market Regulation): Mainly responsible for market supervision, quality control, and anti-monopoly, rather than direct involvement in essential drug pricing.\n\n**Step 4: Cross-verification**\n- According to the latest regulations, the 国家医疗保障局 (National Healthcare Security Administration) is explicitly tasked with responsibilities related to medical insurance, including setting and managing drug prices, particularly for those covered under the national insurance schemes.\n\n**Step 5: Final Confirmation**\n- Based on the analysis, option A, 国家医疗保障局, aligns with the requirement of proposing national essential drug price policy recommendations.\n\nCorrect answer: A",
        "question_type": "最佳选择题",
        "groundtruth": "B",
        "model_choice": "A"
    }
]